Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

The controlling shareholder of anhui xinli finance will change! The 23.60% equity is about to change hands. After turning losses into profits, the performance will once again show a double-digit decline.

①anhui xinli finance holding shareholder "xinli kechuang" intends to transfer all of its approximately 0.121 billion shares to Huilong Investment, with the actual controller still being the Anhui Supply and Marketing Cooperative Union. ②This adjustment may be made by the actual controller to optimize internal resource allocation, with an 11.93% and 23.42% decline in the operating income and net income of Xinli Finance in the first half of the year.

cls.cnSep 19, 2024 10:21 ET

On September 10, 11 companies, including Tiantan Biology and China Satcom, announced positive results.

1. Tiantan Biology: Chengdu Rongsheng related production site has passed the drug GMP compliance test Tiantan Biological announcement, Chengdu Rongsheng developed "Human Coagulation Factor Ⅷ" meets the relevant requirements of drug registration. At the same time, Chengdu Rongsheng related production sites have passed the drug GMP compliance inspection, and obtained the "Drug GMP on-the-spot Inspection result notice" issued by the Sichuan Provincial Drug Administration. two。 China Satcom: China Star 9B satellite will be delivered to the company after passing the in-orbit test. China Satcom announced that the China Star 9B satellite launched on September 9 will be delivered to the company's operation management after passing the in-orbit test.

證券之星Sep 10, 2021 05:58 ET

Comments: the three major indices of A shares rise and fall differently. The concept of the universe skyrocketed and the power stocks set off a wave of stoppage.

On Wednesday, Sept. 8, the three major A-share indexes closed mixed, with the Prev and Shenzhen Composite Index closing almost flat, while the gem closed down nearly 1% at 3219.95 points. In terms of funds, northward capital showed an outflow trend, with a net outflow of more than 1.6 billion yuan, breaking the trend of net inflows for 12 consecutive days. The turnover on the Shanghai and Shenzhen stock markets exceeded 1 trillion yuan for the 36th consecutive trading day. On the market, affected by the good news, the electric power sector led the rise, while 10 shares such as Ningbo Energy and Silver Star Energy rose by the daily limit. Meta-Universe concept stocks continued to be active, and the plate as a whole soared by more than 15%. Zhongqingbao rose by the daily limit for the second day in a row; the seed sector suddenly broke out in the afternoon.

證券之星Sep 8, 2021 03:10 ET

A picture to understand the potassium sulfite International 2021 China News

According to the Securities Star data Center, Asia potassium International 2021 reported that the company's main income was 229 million yuan, up 32.04% from the same period last year; the net profit from its mother was 507 million yuan, up 4791.41% from the same period last year; deducting 29.6334 million yuan from non-net profit, up 194.65% from the same period last year; debt ratio 13.88%, financial expenses 4.1801 million yuan, gross profit margin 47.48%. There are seven new shareholders in this period. Chen Bang holds 5.5008 million shares, accounting for 1.36% of tradable shares, while Duan Xiufeng holds 5.868845 million shares, accounting for 1.46% of tradable shares.

證券之星Aug 30, 2021 12:51 ET